Adverum Biotechnologies I... (ADVM)
NASDAQ: ADVM
· Real-Time Price · USD
2.82
0.05 (1.81%)
At close: Aug 15, 2025, 3:59 PM
2.81
-0.35%
After-hours: Aug 15, 2025, 06:04 PM EDT
Adverum Biotechnologies Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 1M | 1M | 1M | -2.6M | -3.6M | -3.6M | n/a | 3.6M | 3.6M | 3.6M | n/a | -7.5M | -7.5M | -7.5M | n/a | 7.5M | 7.5M | 7.5M |
Cost of Revenue | 9.15M | 9.57M | 9.89M | 3.85M | 4.47M | 10.56M | 9.56M | 10.26M | 10.54M | 5.1M | 6.53M | 12.32M | 11.49M | 11.08M | 9.66M | 2.16M | 1.2M | n/a |
Gross Profit | -11.75M | -12.17M | -12.49M | -6.45M | -8.07M | -14.16M | -9.56M | -6.66M | -6.94M | -1.5M | -6.53M | -19.82M | -18.99M | -18.58M | -9.66M | 5.34M | 6.3M | 7.5M |
Operating Income | -65.49M | -48.54M | -28.46M | -122.87M | -126.68M | -126.84M | -128.94M | -131.77M | -138.28M | -149.24M | -157.13M | -157.61M | -155.1M | -155.61M | -146.12M | -148.08M | -137.56M | -122.8M |
Interest Income | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Income | -156.21M | -137.52M | -115.29M | -112.22M | -117.95M | -118.94M | -123.19M | -126.11M | -133.36M | -145.61M | -154.46M | -156.15M | -154.4M | -154.99M | -145.54M | -147.65M | -137.06M | -121.92M |
Net Income | -183.87M | -153.16M | -130.93M | -94.11M | -99.86M | -112.9M | -117.17M | -126.19M | -133.43M | -145.68M | -154.54M | -156.21M | -154.44M | -155.01M | -145.54M | -148.76M | -138.17M | -123.04M |
Selling & General & Admin | 55.77M | 54.07M | 46.33M | 42.41M | 44.91M | 46.35M | 47.4M | 49.27M | 54.17M | 55.47M | 57.86M | 58.01M | 55.28M | 63.45M | 64.44M | 66.2M | 63.1M | 51.76M |
Research & Development | 110.41M | 90.38M | 77.04M | 68.02M | 68.33M | 71.83M | 77.48M | 84.6M | 87.71M | 97.37M | 99.28M | 99.6M | 99.82M | 92.17M | 89.18M | 89.39M | 81.97M | 78.54M |
Other Expenses | 16.71M | 16.71M | 17.4M | 1.6M | 990K | 2.57M | 2.57M | 2.8M | 3.72M | 2.43M | 2.67M | 1.46M | 697K | 619K | 582K | 434K | 509K | 304K |
Operating Expenses | 182.89M | 161.16M | 140.77M | 112.04M | 114.23M | 119.17M | 125.86M | 133.86M | 141.88M | 152.84M | 157.13M | 157.61M | 155.1M | 155.61M | 153.62M | 155.58M | 145.06M | 130.3M |
Interest Expense | n/a | n/a | n/a | 1.2M | 1.2M | 1.2M | 1.2M | 80.41M | 80.41M | 80.41M | 80.41M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | 7.24M | 7.55M | 6.54M | 6.54M | -706K | -1.01M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 195.01M | 174.24M | 154.16M | 115.89M | 118.7M | 122.68M | 128.38M | 135.37M | 141.88M | 152.84M | 157.13M | 157.61M | 155.1M | 155.61M | 153.62M | 155.58M | 145.06M | 130.3M |
Income Tax Expense | n/a | n/a | n/a | -1.13M | -1.12M | -1.09M | -1.08M | 74K | 74K | 72K | 74K | 55K | 38K | 19K | n/a | -1.11M | -1.11M | -1.11M |
Shares Outstanding (Basic) | 21.01M | 20.94M | 20.9M | 20.88M | 20.85M | 16.48M | 57.98M | 57.98M | 57.98M | 57.98M | 57.98M | 99.47M | 99M | 98.6M | 98.13M | 98.13M | 98.02M | 97.75M |
Shares Outstanding (Diluted) | 21.01M | 20.94M | 20.9M | 20.88M | 20.85M | 16.48M | 57.98M | 57.98M | 57.98M | 57.98M | 57.98M | 99.47M | 99M | 98.6M | 98.13M | 98.13M | 98.02M | 97.75M |
EPS (Basic) | -7.85 | -6.4 | -5.65 | -4.1 | -3.37 | -3.02 | -2.02 | -2.17 | -2 | -1.9 | -1.78 | -1.57 | -1.56 | -1.57 | -1.48 | -1.52 | -1.44 | -1.35 |
EPS (Diluted) | -7.85 | -6.4 | -5.65 | -4.1 | -3.37 | -3.02 | -2.02 | -2.17 | -2 | -1.9 | -1.78 | -1.57 | -1.56 | -1.57 | -1.48 | -1.51 | -1.43 | -1.34 |
EBITDA | -161.36M | -142.24M | -122.06M | -106.56M | -113.34M | -108.24M | -110.74M | -117.12M | -122.42M | -140.12M | -147.93M | -150.02M | -149.09M | -150.09M | -140.9M | -143.25M | -132.42M | -117.18M |
EBIT | -164.28M | -145.58M | -125.71M | -110.42M | -117.81M | -120.38M | -123.47M | -131.77M | -138.28M | -149.24M | -157.13M | -157.61M | -155.1M | -155.61M | -146.12M | -148.08M | -137.56M | -122.8M |
Depreciation & Amortization | 2.92M | 3.34M | 3.65M | 3.85M | 4.47M | 10.56M | 11.15M | 11.86M | 12.13M | 6.7M | 6.53M | 6.14M | 5.31M | 4.9M | 4.64M | 4.4M | 4.62M | 4.72M |